FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: No evidence for association with risk for breast cancer

Breast Cancer Research and Treatment

Volumn 130, Issue 3, 2011, Pages 1043-1049

  Park, Daniel J ^a   Odefrey, Fabrice A ^a   Hammet, Fleur ^a   Giles, Graham G ^a,b   Baglietto, Laura ^a,b   Abcfs, ^c   McCs, ^d   Hopper, John L ^a   Schmidt, Daniel F ^a   Makalic, Enes ^a   Sinilnikova, Olga M ^e,f   Goldgar, David E ^g   Southey, Melissa C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c Australian Breast Cancer Family Study   (Australia)

^d Melbourne Collaborative Cohort Study   (Australia)

^e UNIVERSITÉ LYON 1   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; FAN1; Massively parallel sequencing; Whole exome sequencing

Indexed keywords

ADENINE; ARGININE; CYTOSINE; GUANINE; THYMINE; TRYPTOPHAN;

ADULT; AGED; ARTICLE; AUSTRALIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SEQUENCE; ETHNIC GROUP; EXOME; FAMILIAL CANCER; FAN1 GENE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AUSTRALIA; BREAST NEOPLASMS; EXODEOXYRIBONUCLEASES; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; PEDIGREE;

EID: 82255191753     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1704-y     Document Type: Article

References (39)

1. C Turnbull S Hines A Renwick D Hughes D Pernet A Elliott S Seal M Warren-Perry DG Evans D Eccles Breast Cancer Susceptibility Collaboration (UK) MR Stratton N Rahman 2010 Mutation and association analysis of GEN1 in breast cancer susceptibility Breast Cancer Res Treat 124 283 288 20512659 1:CAS:528:DC%2BC3cXht1elsLzO 10.1007/s10549-010-0949-1
2. A Bonnefond P Froguel M Vaxillaire 2010 The emerging genetics of type 2 diabetes Trends Mol Med 16 407 416 20728409 1:CAS:528:DC%2BC3cXhtFajs7zK 10.1016/j.molmed.2010.06.004
3. OM Serova S Mazoyer N Puget V Dubois P Tonin YY Shugart D Goldgar SA Narod HT Lynch GM Lenoir 1997 Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60 486 495 9042907 1:CAS:528:DyaK2sXhvFGjtLk%3D (Pubitemid 27097596)
4. Southey MC, Teo ZL, Dowty JG, Odefrey FA, Park DJ, Tischkowitz M, Sabbaghian N, Apicella C, Byrnes GB, Winship I, Breast Cancer Family Registry, KConFab, Baglietto L, Giles GG, Goldgar D, Foulkes WD, Hopper JL (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res 12:R109
5. J Mouchawar C Korch T Byers TM Pitts, et al. 2010 Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian breast cancer family study Cancer Res 70 4795 4800 20501846 1:CAS:528:DC%2BC3cXntlKltr0%3D 10.1158/0008-5472.CAN-09-0851
6. SL Neuhausen H Ozcelik MC Southey, et al. 2009 BRCA1 and BRCA2 mutation carriers in the breast cancer family registry: an open resource for collaborative research Breast Cancer Res Treat 116 379 386 18704680 1:CAS:528:DC%2BD1MXntF2ntr4%3D 10.1007/s10549-008-0153-8
7. C Apicella JG Dowty GS Dite MA Jenkins, et al. 2003 Log odds of carrying an ancestral mutation in BRCA1 or BRCA2 for a defined personal and family history in an ashkenazi jewish woman (LAMBDA) Breast Cancer Res 5 R206 R216 14580256 10.1186/bcr644
8. G Chenevix-Trench AB Spurdle M Gatei H Kelly, et al. 2002 Dominant negative ATM mutations in breast cancer families J Natl Cancer Inst 94 205 215 11830610 10.1093/jnci/94.3.205 (Pubitemid 34162754)
9. JL Bernstein S Teraoka MC Southey MA Jenkins IL Andrulis JA Knight EM John R Lapinski AL Wolitzer AS Whittemore D West D Seminara ER Olson AB Spurdle G Chenevix-Trench GG Giles JL Hopper P Concannon 2006 Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the breast cancer family registry Hum Mutat 27 1122 1128 16958054 1:CAS:528:DC%2BD28Xht1GktLfL 10.1002/humu.20415 (Pubitemid 44730507)
10. IL Andrulis H Anton-Culver J Beck B Bove, et al. 2002 Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations Hum Mutat 20 65 73 12112659 1:CAS:528:DC%2BD38XlslKrtrc%3D 10.1002/humu.10097 (Pubitemid 34747718)
11. GS Dite MA Jenkins MC Southey, et al. 2003 Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations J Natl Cancer Inst 95 448 457 12644538 1:CAS:528:DC%2BD3sXisFCqsrc%3D 10.1093/jnci/95.6.448 (Pubitemid 36432419)
12. LD Smith AA Tesoriero SJ Ramus, et al. 2007 BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study Eur J Cancer 43 823 827 17317153 1:CAS:528:DC%2BD2sXisleit7Y%3D 10.1016/j.ejca.2007.01.011 (Pubitemid 46366692)
13. MC Southey AA Tesoriero CR Andersen KM Jennings, et al. 1999 BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer Br J Cancer 79 34 39 10408690 1:CAS:528: DyaK1MXmvVKlsQ%3D%3D 10.1038/sj.bjc.6690008 (Pubitemid 28566923)
14. F Le Calvez-Kelm F Lesueur F Damiola M Vallee C Voegele D Babikyan G Durand N Forey S McKay-Chopin N Robinot T Nguyen-Dumont A Thomas GB Byrnes Breast Cancer Family Registry JL Hopper MC Southey IL Andrulis EM John SV Tavtigian 2011 Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study Breast Cancer Res 13 R6 21244692 10.1186/bcr2810
15. MR McCredie GS Dite GG Giles JL Hopper 1998 Breast cancer in Australian women under the age of 40 Cancer Causes Control 9 189 198 9578296 1:STN:280:DyaK1c3jslCjtQ%3D%3D 10.1023/A:1008886328352 (Pubitemid 28160974)
16. JL Hopper GG Giles MR McCredie P Boyle 1994 Background rational and protocol for a case-control-family study of breast cancer Breast 3 79 86 10.1016/0960-9776(94)90003-5 (Pubitemid 24158996)
17. JL Hopper G Chenevix-Trench DJ Jolley, et al. 1999 Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the cooperative family registry for breast cancer studies (CFRBCS) J Natl Cancer Inst Monogr 26 95 100 10854492
18. EM John JL Hopper JC Beck JA Knight SL Neuhausen RT Senie A Ziogas I Andrulis H Anton-Culver N Boyd SS Buys MB Daly FP O'Malley RM Santella MC Southey VL Venne DJ Venter DW West AS Whittemore D Seminara The Breast Cancer Family Registry 2004 The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res 6 R375 R389 15217505 10.1186/bcr801
19. S Ahmed G Thomas M Ghoussaini CS Healey, et al. 2009 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 Nature Genet 41 585 590 19330027 1:CAS:528:DC%2BD1MXjsl2gu7c%3D 10.1038/ng.354
20. GG Giles DR English 2002 The Melbourne Collaborative Cohort Study IARC Sci Publ 156 69 70 12484128 1:STN:280:DC%2BD38jit1eqtw%3D%3D
21. DF Easton KA Pooley AM Dunning PDP Pharoah, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 1087 1093 17529967 1:CAS:528:DC%2BD2sXmvFKmurc%3D 10.1038/nature05887 (Pubitemid 47014426)
22. G-L Moldovan AD D'Andrea 2009 How the fanconi anemia pathway guards the genome Annu Rev Genet 43 223 249 19686080 1:CAS:528:DC%2BD1MXhsF2qtrnO 10.1146/annurev-genet-102108-134222
23. LH Thompson JM Hinz 2009 Cellular and molecular consequences of defective fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights Mutat Res 668 54 72 19622404 1:CAS:528:DC%2BD1MXos12rurw%3D 10.1016/j.mrfmmm.2009.02.003
24. G Fanconi 1967 Familial constitutional panmyelocytopathy, fanconi's anemia (F.A.). I. clinical aspects Semin Hematol 4 233 240 6074578 1:STN:280:DyaF1c%2FpsVGjtg%3D%3D
25. W Schmid G Fanconi 1978 Fragility and spiralization anomalies of the chromosomes in three cases, including fraternal twins, with fanconi's anemia, type estren-dameshek Cytogenet Cell Genet 20 141 149 648172 1:STN:280: DyaE1c7mvVaitw%3D%3D 10.1159/000130845 (Pubitemid 8319141)
26. BP Alter MH Greene I Velazquez PS Rosenberg 2003 Cancer in fanconi anemia Blood 101 2072 12584146 1:CAS:528:DC%2BD3sXhslCrurg%3D 10.1182/blood-2002-11- 3597 (Pubitemid 36237620)
27. AD Auerbach SR Wolman 1976 Susceptibility of fanconi's anemia fibroblasts to chromosome damage by carcinogens Nature 261 494 496 934283 1:CAS:528:DyaE28XltVGjtrw%3D 10.1038/261494a0
28. NG Howlett T Taniguchi S Olson B Cox Q Waisfisz C Die-Smulders N Persky M Grompe H Joenje G Pals H Ikeda EA Fox AD D'Andrea 2002 Biallelic inactivation of BRCA2 in fanconi anemia Science 297 606 609 12065746 1:CAS:528: DC%2BD38XlslWrs7k%3D 10.1126/science.1073834 (Pubitemid 34815345)
29. B Xia JC Dorsman N Ameziane Y de Vries MA Rooimans Q Sheng G Pals A Errami E Gluckman J Llera W Wang DM Livingston H Joenje JP de Winter 2007 Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Nat Genet 39 159 161 17200672 1:CAS:528:DC%2BD2sXpvFekug%3D%3D 10.1038/ng1942 (Pubitemid 46184344)
30. M Levitus Q Waisfisz BC Godthelp Y de Vries S Hussain WW Wiegant E Elghalbzouri-Maghrani J Steltenpool MA Rooimans G Pals F Arwert CG Mathew MZ Zdzienicka K Hiom JP De Winter H Joenje 2005 The DNA helicase BRIP1 is defective in fanconi anemia complementation group J Nat Genet 37 934 935 16116423 1:CAS:528:DC%2BD2MXpsFWisb0%3D 10.1038/ng1625 (Pubitemid 43086148)
31. AR Meetei S Sechi M Wallisch D Yang MK Young H Joenje ME Hoatlin W Wang 2003 A multiprotein nuclear complex connects fanconi anemia and bloom syndrome Mol Cell Biol 23 3417 3426 12724401 1:CAS:528:DC%2BD3sXjs1yhsb8%3D 10.1128/MCB.23.10.3417-3426.2003 (Pubitemid 36539175)
32. K Gari C Decaillet AZ Stasiak A Stasiak A Constantinou 2008 The fanconi anemia protein FANCM can promote branch migration of holliday junctions and replication forks Mol Cell 29 141 148 18206976 1:CAS:528:DC%2BD1cXhtlWjtLY%3D 10.1016/j.molcel.2007.11.032
33. A Smogorzewska R Desetty TT Saito M Schlabach FP Lach ME Sowa AB Clark TA Kunkel JW Harper MP Colaiácovo SJ Elledge 2010 A genetic screen identifies FAN1, a fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair Mol Cell 39 36 47 20603073 1:CAS:528: DC%2BC3cXpsFejsrw%3D 10.1016/j.molcel.2010.06.023
34. K Kratz KadenS Schöpf A Sendoel R Eberhard C Lademann E Cannavó AA Sartori MO Hengartner J Jiricny 2010 Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents Cell 142 77 88 20603016 1:CAS:528:DC%2BC3cXpt1CjtL8%3D 10.1016/j.cell.2010.06.022
35. C MacKay A-C Déclais C Lundin A Agostinho AJ Deans TJ MacArtney K Hofmann A Gartner SC West T Helleday DMJ Lilley J Rouse 2010 Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinylated FANCD2 Cell 142 65 76 20603015 1:CAS:528: DC%2BC3cXpt1CjtL4%3D 10.1016/j.cell.2010.06.021
36. T Liu G Ghosal J Yuan J Chen J Huang 2010 FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair Science 329 693 696 20671156 1:CAS:528:DC%2BC3cXps1ehtbo%3D 10.1126/science.1192656
37. GB Byrnes MC Southey JL Hopper 2008 Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? Breast Cancer Res 10 208 214 18557994 10.1186/bcr2099
38. AC Antoniou X Wang ZS Fredericksen, et al. 2010 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population Nat Genet 42 885 892 20852631 1:CAS:528:DC%2BC3cXhtFOht73M 10.1038/ng.669
39. L Walker ZS Fredericksen X Wang, et al. 2010 Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers Breast Cancer Res 12 R102 21114847 1:CAS:528:DC%2BC3cXhsFGqu7fM 10.1186/bcr2785